Brief: Bioage Labs Announces Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions
18/12/2024 15:02
Dec 18 (Reuters) - BIOAGE Labs Inc BIOA.O :
* BIOAGE LABS ANNOUNCES MULTI-YEAR COLLABORATION WITH
NOVARTIS TO
DISCOVER NOVEL TARGETS FOR THERAPIES THAT ADDRESS AGE-RELATED
DISEASES AND CONDITIONS
* NOVARTIS TO PAY UP TO $20M IN UPFRONT PAYMENTS AND
RESEARCH
FUNDING
* MAY RECEIVE UP TO $530M IN FUTURE MILESTONES
Source text: ID:nGNX8BPn2d
Further company coverage: BIOA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioAge Labs
See all newsBrief: Bioage Labs Announces First Participant Dosed In Quell-Dme, A Phase 2 Trial Of Bge-102, A Novel Oral Nlrp3 Inhibitor, In Diabetic Macular Edema
BioAge Labs, Inc. reports results for the quarter ended June 30 - Earnings Summary
BioAge Labs Q1 collaboration revenue beats estimates on Novartis collaboration
BioAge Labs full-year collaboration revenue beats estimates
U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP